Unknown

Dataset Information

0

Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.


ABSTRACT: Background.:Evidence-based recommendations for treating persons having presumed latent tuberculosis (LTBI) after contact to infectious multidrug-resistant (MDR) tuberculosis (TB) are lacking because published data consist of small observational studies. Tuberculosis incidence in persons treated for latent MDR -TB infection is unknown. Methods.:We conducted a systematic review of studies published 1 January 1994-31 December 2014 to analyze TB incidence, treatment completion and discontinuation, and cost-effectiveness. We considered contacts with LTBI effectively treated if they were on ?1 medication to which their MDR-TB strain was likely susceptible. We selected studies that compared treatment vs nontreatment outcomes and performed a meta-analysis to estimate the relative risk of TB incidence and its 95% confidence interval. Results.:We abstracted data from 21 articles that met inclusion criteria. Six articles presented outcomes for contacts who were treated compared with those not treated for MDR-LTBI; 10 presented outcomes only for treated contacts, and 5 presented outcomes only for untreated contacts. The estimated MDR-TB incidence reduction was 90% (9%-99%) using data from 5 comparison studies. We also found high treatment discontinuation rates due to adverse effects in persons taking pyrazinamide-containing regimens. Cost-effectiveness was greatest using a fluoroquinolone/ethambutol combination regimen. Conclusions.:Few studies met inclusion criteria, therefore results should be cautiously interpreted. We found a reduced risk of TB incidence with treatment for MDR-LTBI, suggesting effectiveness in prevention of progression to MDR-TB, and confirmed cost-effectiveness. However, we found that pyrazinamide-containing MDR-LTBI regimens often resulted in treatment discontinuation due to adverse effects.

SUBMITTER: Marks SM 

PROVIDER: S-EPMC5543758 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.

Marks Suzanne M SM   Mase Sundari R SR   Morris Sapna Bamrah SB  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20170601 12


<h4>Background.</h4>Evidence-based recommendations for treating persons having presumed latent tuberculosis (LTBI) after contact to infectious multidrug-resistant (MDR) tuberculosis (TB) are lacking because published data consist of small observational studies. Tuberculosis incidence in persons treated for latent MDR -TB infection is unknown.<h4>Methods.</h4>We conducted a systematic review of studies published 1 January 1994-31 December 2014 to analyze TB incidence, treatment completion and dis  ...[more]

Similar Datasets

| S-EPMC1483913 | biostudies-literature
| S-EPMC5537756 | biostudies-other
| S-EPMC1564168 | biostudies-literature
| S-EPMC7908776 | biostudies-literature
| S-EPMC7802168 | biostudies-literature
| S-EPMC5829942 | biostudies-literature
| S-EPMC3574085 | biostudies-literature
| S-EPMC5862834 | biostudies-literature
| S-EPMC9246177 | biostudies-literature
| S-EPMC4622252 | biostudies-literature